Do patients participating in clinical trials want to know study results?

被引：62

作者：

Partridge, AH

Burstein, HJ

Gelman, RS

Marcom, PK

Winer, EP

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Boston, MA USA

[5] Duke Univ, Med Ctr, Durham, NC USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2003年 / 95卷 / 06期

关键词：

D O I：

10.1093/jnci/95.6.491

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：491 / 492

页数：2

共 5 条

[1] Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer [J].

Burstein, HJ ;

Kuter, I ;

Campos, SM ;

Gelman, RS ;

Tribou, L ;

Parker, LM ;

Manola, J ;

Younger, J ;

Matulonis, U ;

Bunnell, CA ;

Partridge, AH ;

Richardson, PG ;

Clarke, K ;

Shulman, LN ;

Winer, EP .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2722-2730

[2]

*CANC RES FDN AM C, SUMM SER CLIN TRIALS

[3]

*COAL NAT CANC COO, 2002, GUID NOT PAT EARL CL

[4] Informing clinical trial participants about study results [J].

Partridge, AH ;

Winer, EP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :363-365

[5]

SHURIN S, 2001, CHILDRENS ONCOLOGY N, V2, P14

← 1 →